ICH – ICH targets cell and gene therapies, real-world data as topics ripe for harmonization
Officials from Health Canada and the pharmaceutical industry addressed plans to develop harmonized guidelines on cell and gene therapies and on the design of pharmacoepidemiological studies that use real-world data (RWD) to assess new medicines at the International Council for Harmonisation (ICH) regional meeting sponsored by the US Food and Drug Administration (FDA) and Health Canada.
More information on Regulatory Focus.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (25 juillet 2024). ICH – ICH targets cell and gene therapies, real-world data as topics ripe for harmonization. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/123mz





